Sarki A. Abdulkadir, MD, PhD, discusses the challenges of targeting MYC in prostate cancer.
Sarki A. Abdulkadir, MD, PhD
Advertisement
Articles by Sarki A. Abdulkadir, MD, PhD
Sarki A. Abdulkadir, MD, PhD, discusses the rationale to target MYC in prostate cancer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts Third RP1 BLA Resubmission With Nivolumab in Advanced Melanoma
2
Real-World Mogamulizumab Elicits Durable Responses in Pretreated Mycosis Fungoides and Sézary Syndrome
3
From "Not Curable" to "May Be Curable": Joshua Richter, MD, on the New Reality of Multiple Myeloma
4
MAIC Shows OS Benefit With Mogamulizumab vs Vorinostat in Cutaneous T-Cell Lymphoma Subtypes
5